Conjugates having an enzymmatically releasable detection moiety and a barcode moiety

Patent metadata

Field	Value
Publication number	US-12436151-B2
Application number	US-202017601054-A
Country	US
Kind code	B2
Filing date	Apr 6, 2020
Priority date	Apr 12, 2019
Publication date	Oct 7, 2025
Grant date	Oct 7, 2025

Abstract

The invention is directed to a conjugate having the general formula (I)

X n —P—Y m B o   (I)
with X is an detection moiety, P is a spacer unit, Y an antigen recognizing moiety, B an oligonucleotide comprising 2 to 100 nucleotide residues and n, m, o are independent integers between 1 and 100 wherein P and B are covalently bound to Y and X is covalently bound to P and wherein X is erasable.

Further, the invention is directed to a library of such conjugates and a method of detecting target cells utilizing the conjugates or the library of conjugates.

First claim

The invention claimed is:

1. A conjugate having the general formula (I)
Xn-P-YmBo  (I)

with X is an detection moiety,
P is a spacer unit,
Y an antigen recognizing moiety,
B an oligonucleotide comprising 2 to 100 nucleotide residues
and n, m, o are independent integers between 1 and 100
wherein P and B are covalently bound to Y and X is covalently bound to P and wherein X is erasable by eliminating the fluorescence emission of the detection moiety through radiation or enzymatic degradation of the spacer unit P, and wherein the antigen recognizing moiety Y and/or the oligonucleotide B comprises a crosslinker unit as a functional group that forms a covalent bond with the antigen recognized by the antigen recognizing moiety Y.

2. The conjugate according to claim 1 characterized in that the spacer unit P is enzymatic degradable.

3. The conjugate according to claim 1 , characterized in that that the covalent bond of the crosslinker to an antigen is initiated by radiation or enzymatic reaction.

4. The conjugate according to claim 1 , characterized in that the detection moiety is selected from the group consisting of chromophore moiety, fluorescent moiety, phosphorescent moiety, luminescent moiety, light absorbing moiety, radioactive moiety, transition metal and isotope mass tag moiety.

5. The conjugate according to claim 1 , characterized in that the enzymatically degradable spacer P is selected from the group consisting of polysaccharides, proteins, peptides, depsipeptides, polyesters, nucleic acids, and derivatives thereof.

6. The conjugate according to claim 1 , characterized in that the antigen recognizing moiety Y is an antibody, an fragmented antibody, an fragmented antibody derivative, peptide/MHC-complexes targeting TCR molecules, cell adhesion receptor molecules, receptors for costimulatory molecules or artificial engineered binding molecules.

7. A library of conjugates according to claim 1 , comprising at least 10000 conjugates provided with oligonucleotide B having nucleotide sequences that differ by at least one nucleotide.

8. A method for detecting a target moiety on a cell by:
a) providing at least one conjugate having the general formula (I)
Xn-P-YmBo  (I)

with X is an detection moiety,
P is a spacer unit,
Y an antigen recognizing moiety,
B an oligonucleotide comprising 2 to 100 nucleotide residues
and n, m, o are independent integers between 1 and 100

wherein P and B are covalently bound to Y and X is covalently bound to P and wherein X is erasable; and
b) contacting the sample of biological specimens with the at least one conjugate, thereby labelling the target moiety recognized by the antigen recognizing moiety Y c) detecting the target moiety labelled with the conjugate with the detecting moiety X d) isolating the cell labelled with the conjugate with the detecting moiety X e) erasing detection moiety X, by eliminating the fluorescence emission of the detection moiety through radiation or enzymatic degradation of the spacer unit P, and wherein the antigen recognizing moiety Y and/or the oligonucleotide B comprises a crosslinker unit as a functional group that forms a covalent bond with the antigen recognized by the antigen recognizing moiety Y.

9. The method according to claim 8 characterized in that the detection moiety X is erased by radiation or by enzymatic degradation of spacer unit P.

10. The method according to claim 8 characterized in that that the antigen recognizing moiety Y and/or the oligonucleotide B is provided with a crosslinker unit capable of providing a covalent bound to the antigen recognized by antigen recognizing moiety Y and that the covalent bound of the crosslinker to the antigen is initiated by radiation or enzymatic reaction.

11. The method according to claim 8 characterized in that steps a) to e) are repeated subsequently at least with two conjugates having different antigen recognizing moieties Y.

12. The method according to claim 8 characterized in that steps a) to e) are repeated subsequently at least with two conjugates having different antigen recognizing moieties Y and different oligonucleotides B.

Assignees

• Miltenyi Biotec Bv & Co Kg

Inventors

• Bosio Andreas

Classifications

• G01N2458/10

  Oligonucleotides as tagging agents for labelling antibodies · CPC title

• C40B30/04 Primary

  by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding · CPC title

• G01N33/58 Primary

  involving labelled substances (G01N33/53 takes precedence) · CPC title